The REACTOME pathway analysis of the 23 hub genes further confirmed that the altered biological mechanisms found in CD56+ CTCs correspond to those found in SCLC, with the addition of the p53 signaling pathways (Supplemental Fig. S3D). This evidence concerns the gene TP53 and small cell lung carcinoma.